Admetsys Overview

  • Year Founded
  • 2014

Year Founded

  • Status
  • Private

  • Employees
  • 4

Employees

  • Latest Deal Type
  • Accelerator/​Inc

  • Investors
  • 16

Admetsys General Information

Description

Developer of a clinical robotic system designed for blood analysis and metabolic control. The company's real-time diagnostic platform uses a standard IV line, which draws a small blood sample every few minutes to measure glucose electrochemically and returns the blood back to the patient along with a closed-loop artificial pancreas in hospital and surgical care and remote monitoring applications, enabling hospitals to effectively control blood glucose levels and alleviate stresses associated with diabetic care.

Contact Information

Website
www.admetsys.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 4 South Market Street
  • Building 4 Floor 4
  • Boston, MA 02109
  • United States
+1 (800) 000-0000
Primary Industry
Monitoring Equipment
Other Industries
Other Healthcare Technology Systems
Vertical(s)
Digital Health, HealthTech, Life Sciences
Corporate Office
  • 4 South Market Street
  • Building 4 Floor 4
  • Boston, MA 02109
  • United States
+1 (800) 000-0000

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Admetsys Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
13. Accelerator/Incubator 01-Jan-2019 00.000 Completed Generating Revenue
12. Grant 01-Jan-2018 0000 00.000 Completed Generating Revenue
11. Early Stage VC 06-Jun-2017 00.00 00.000 Completed Generating Revenue
10. Early Stage VC 27-Apr-2017 00000 00.000 Completed Generating Revenue
9. Accelerator/Incubator 28-Jun-2016 00.000 Completed Generating Revenue
8. Accelerator/Incubator 08-Mar-2016 000 00.000 Completed Generating Revenue
7. Accelerator/Incubator 29-Jul-2015 000.00 Completed Startup
6. Accelerator/Incubator 14-Jul-2015 000.00 Completed Startup
5. Accelerator/Incubator 24-Jun-2015 $37.4K Completed Startup
4. Grant 15-Apr-2015 $3.5K $37.4K Completed Startup
To view Admetsys’s complete valuation and funding history, request access »

Admetsys Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of a clinical robotic system designed for blood analysis and metabolic control. The company's real-time diagno
Monitoring Equipment
Boston, MA
4 As of 2024
00.000
000000000000 00.000

000000

fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt in
0000000000 000000000
San Diego, CA
00 As of 0000
000.00
0000 0000-00-00
00000000000 000.00

000000

nderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur
0000000000 000000000
San Diego, CA
0000 As of 0000
00000
000000000 00000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Admetsys Competitors (13)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
GlySens Venture Capital-Backed San Diego, CA 00 000.00 00000000000 000.00
DexCom Formerly VC-backed San Diego, CA 0000 00000 000000000 00000
Ascensia Diabetes Care Formerly PE-Backed Basel, Switzerland 0000 000000000000
LifeScan Private Equity-Backed Malvern, PA 0000 00000 0000000 0000 00000
GlucoTrack Corporation Rutherford, NJ 0 000.00 000000000 000.00
You’re viewing 5 of 13 competitors. Get the full list »

Admetsys Patents

  • 27

    Total Documents Applications and Grants

  • 000

    Total Patents Families

  • 21

    Granted

  • 2

    Pending

  • 000

    Expiring in next 12 mo

Admetsys Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20210038877-A1 Intravascular port based sensing and treatment system Inactive 12-Mar-2018 00000000000 0
US-20230131362-A1 Intraosseous implanted biological sensor Inactive 12-Mar-2018 0000000000 0
US-11357425-B2 Intraosseous implanted biological sensor Active 12-Mar-2018 0000000000 0
US-20210038130-A1 Intraosseous implanted biological sensor Active 12-Mar-2018 0000000000
US-11621071-B2 System and method for clinical quality and safety automation Active 12-Mar-2018 G06Q10/087 0
To view Admetsys’s complete patent history, request access »

Admetsys Executive Team (3)

Name Title Board Seat
Jeffrey Valk Co-Founder, Chief Executive Officer, and President
Glenn Robertelli Co-Founder, Chief Operating Officer and Executive Board Member
Timothy Valk MD Co-Founder & Chief Scientist
To view Admetsys’s complete executive team members history, request access »

Admetsys Board Members (1)

Name Representing Role Since
Glenn Robertelli Admetsys Co-Founder, Chief Operating Officer and Executive Board Member 000 0000
To view Admetsys’s complete board members history, request access »

Admetsys Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Admetsys Investors (16)

Investor Name Investor Type Holding Investor Since Participating Rounds
Mohammed Bin Rashid Innovation Fund Accelerator/Incubator 000 0000 000000 0
Texas A&M New Ventures Competition University 000 0000 000000 0
Baptist Health System Corporation 000 0000 000000 0
BlueCross and BlueShield Association Corporation 000 0000 000000 0
T1D Exchange Corporation 000 0000 000000 0
You’re viewing 5 of 16 investors. Get the full list »

Ready to get started?

Request a free trial

Admetsys FAQs

  • When was Admetsys founded?

    Admetsys was founded in 2014.

  • Who is the founder of Admetsys?

    Jeffrey Valk, Glenn Robertelli, and Timothy Valk MD are the founders of Admetsys.

  • Who is the CEO of Admetsys?

    Jeffrey Valk is the CEO of Admetsys.

  • Where is Admetsys headquartered?

    Admetsys is headquartered in Boston, MA.

  • What is the size of Admetsys?

    Admetsys has 4 total employees.

  • What industry is Admetsys in?

    Admetsys’s primary industry is Monitoring Equipment.

  • Is Admetsys a private or public company?

    Admetsys is a Private company.

  • What is Admetsys’s current revenue?

    The current revenue for Admetsys is 00000.

  • How much funding has Admetsys raised over time?

    Admetsys has raised $2.69M.

  • Who are Admetsys’s investors?

    Mohammed Bin Rashid Innovation Fund, Texas A&M New Ventures Competition, Baptist Health System, BlueCross and BlueShield Association, and T1D Exchange are 5 of 16 investors who have invested in Admetsys.

  • Who are Admetsys’s competitors?

    GlySens, DexCom, Ascensia Diabetes Care, LifeScan, and GlucoTrack are some of the 13 competitors of Admetsys.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »